Table 1. Comparison of CIBERSORT immune cell fractions between tumor and non-tumor tissues from HCC patients.

Immune cell type	CIBERSORT fraction in % of all infiltrating immune cells (mean ± SD)
	Tumors (n=14)	Non-tumors (n=14)	P value
T cells CD8	0.140±0.071	0.192±0.073	0.075
T cells CD4 naive	0.0±0.0	0.0±0.0	1.0
T cells CD4 memory resting	0.071±0.082	0.088±0.066	0.553
T cells CD4 memory activated	0.002±0.008	0.0±0.001	0.408
T cells follicular helper	0.074±0.030	0.066±0.030	0.545
T cells regulatory (Tregs)	0.066±0.040	0.011±0.017	<0.001
T cells gamma delta	0.004±0.009	0.012±0.017	0.109
B cells naive	0.013±0.017	0.020±0.027	0.454
B cells memory	0.022±0.026	0.008±0.016	0.133
Plasma cells	0.065±0.025	0.061±0.022	0.658
NK cells resting	0.008±0.016	0.006±0.009	0.709
NK cells activated	0.040±0.021	0.017±0.019	0.007
Macrophages M0	0.043±0.041	0.0±0.003	0.001
Macrophages M1	0.090±0.030	0.090±0.033	0.965
Macrophages M2	0.143±0.081	0.169±0.054	0.351
Monocytes	0.033±0.024	0.056±0.034	0.056
Dendritic cells resting	0.074±0.059	0.043±0.024	0.085
Dendritic cells activated	0.003±0.007	0.0±0.0	0.160
Mast cells resting	0.003±0.011	0.001±0.003	0.505
Mast cells activated	0.081±0.055	0.125±0.144	0.318
Eosinophils	0.0±0.0	0.0±0.0	1.0
Neutrophils	0.026±0.020	0.033±0.015	0.313

Italic P values indicate significance between individual groups. HCC, hepatocellular carcinoma.